ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

Accuracy Of Diagnostic Mammograms Varies By Radiologist, Study Finds

December 28, 2007

Smoking/Health Program Seeks Grants; Ideas For RFAs RFPs Being Considered

December 5, 1980

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987

DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants

October 28, 1988